COURTNEY DRAIN: Open Payments
NPI 1285397240 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 49 payments from 11 companies in 2025. Trend: 2023 $154 · 2024 $390 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $474 |
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Braeburn Inc. | 2 | $45 |
| Alkermes, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Lundbeck LLC | 1 | $29 |
| Verona Pharma, Inc. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $16 |
Products named: VRAYLAR, BREZTRI, TRELEGY ELLIPTA, BRIXADI, AIRSUPRA, VIVITROL, CAPLYTA, REXULTI.
Industry payments across AR — which companies pay providers there.
